Lactiplantibacillus plantarum NKK20 Alleviates High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Regulating Bile Acid Anabolism
Molecules · 2023
DOI: 10.3390/molecules28104042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Chang Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Zhenjiang Key Research and Development Plan - Social Development Project.
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic disease in modern society. It is characterized by an accumulation of lipids in the liver and an excessive inflammatory response. Clinical trials have provided evidence that probiotics may prevent the onset and relapse of NAFLD. The aim of this study was to explore the effect of Lactiplantibacillus plantarum NKK20 strain (NKK20) on high-fat-diet-induced NAFLD in an ICR murine model and propose the underlying mechanism whereby NKK20 protects against NAFLD. The results showed that the administration of NKK20 ameliorated hepatocyte fatty degeneration, reduced total cholesterol and triglyceride concentrations, and alleviated inflammatory reactions in NAFLD mice. In addition, the 16S rRNA sequencing results indicated that NKK20 could decrease the abundance of Pseudomonas and Turicibacter and increase the abundance of Akkermansia in NAFLD mice. LC-MS/MS analysis showed that NKK20 could significantly increase the concentration of short-chain fatty acids (SCFAs) in the colon contents of mice. The obtained non-targeted metabolomics results revealed a significant difference between the metabolites in the colon contents of the NKK20 administration group and those in the high-fat diet group, in which a total of 11 different metabolites that were significantly affected by NKK20 were observed, and these metabolites were mainly involved in bile acid anabolism. UPLC-MS technical analysis revealed that NKK20 could change the concentrations of six conjugated and free bile acids in mouse liver. After being treated with NKK20, the concentrations of cholic acid, glycinocholic acid, and glycinodeoxycholic acid in livers of the NAFLD mice were significantly decreased, while the concentration of aminodeoxycholic acid was significantly increased. Thus, our findings indicate that NKK20 can regulate bile acid anabolism and promote the production of SCFA, which can inhibit inflammation and liver damage and thus prevent the development of NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China.
- Department of Stomatology, Zhenjiang First People's Hospital, Zhenjiang 212002, China.
- Department of Testing Center, Yangzhou University, Yangzhou 225001, China.
- Zhenjiang Center for Disease Control and Prevention, Zhenjiang 212002, China.
- School of Grain Science and Technology, Jiangsu University of Science and Technology, Zhenjiang 212100, China.
- Department of Laboratory Medicine, Lianyungang Second People's Hospital Affiliated to Jiangsu University, Lianyungang 222006, China.
ORCID-Profile: Dongxu Wang, Liang Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Zhenjiang Key Research and Development Plan - Social Development Project
- First People's Hospital of Zhenjiang hospital Scientific Research Fundation
- Zhenjiang Key Research and Development Plan—Social Development Project
- First People’s Hospital of Zhenjiang hospital Scientific Research Fund
Zitieren
APA
Sun, C., Qiu, C., Zhang, Y., Yan, M., Tan, J., He, J., Yang, D., Wang, D., & Wu, L. (2023). Lactiplantibacillus plantarum NKK20 Alleviates High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Regulating Bile Acid Anabolism. Molecules. https://doi.org/10.3390/molecules28104042
Vancouver
Sun C, Qiu C, Zhang Y, Yan M, Tan J, He J, et al. Lactiplantibacillus plantarum NKK20 Alleviates High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Regulating Bile Acid Anabolism. Molecules. 2023. doi:10.3390/molecules28104042
BibTeX
@article{Sun2023,
author = {Sun, Chang and Qiu, Chenguang and Zhang, Yanyan and Yan, Man and Tan, Jiajun and He, Jiayuan and Yang, Dakai and Wang, Dongxu and Wu, Liang},
title = {Lactiplantibacillus plantarum NKK20 Alleviates High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Regulating Bile Acid Anabolism},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28104042}
}
EUVIMED